|
1
|
Ostrom QT, Gittleman H, Liao P, Rouse C,
Chen Y, Dowling J, Wolinsky Y, Kruchko C and Barnholtz-Sloan J:
CBTRUS statistical report: Primary brain and central nervous system
tumors diagnosed in the United States in 2007-2011. Neuro Oncol. 16
(Suppl 4):iv1–iv63. 2014.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Wirsching HG, Galanis E and Weller M:
Glioblastoma. Handb Clin Neurol. 134:381–397. 2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Stupp R, Mason WP, van den Bent MJ, Weller
M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn
U, et al: Radiotherapy plus concomitant and adjuvant temozolomide
for glioblastoma. N Engl J Med. 352:987–996. 2005.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Gilbert MR, Dignam JJ, Armstrong TS, Wefel
JS, Blumenthal DT, Vogelbaum MA, Colman H, Chakravarti A, Pugh S,
Won M, et al: A randomized trial of bevacizumab for newly diagnosed
glioblastoma. N Engl J Med. 370:699–708. 2014.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Gilbert MR, Wang M, Aldape KD, Stupp R,
Hegi ME, Jaeckle KA, Armstrong TS, Wefel JS, Won M, Blumenthal DT,
et al: Dose-dense temozolomide for newly diagnosed glioblastoma: A
randomized phase III clinical trial. J Clin Oncol. 31:4085–4091.
2013.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Stupp R, Hegi ME, Mason WP, van den Bent
MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B,
Belanger K, et al: Effects of radiotherapy with concomitant and
adjuvant temozolomide versus radiotherapy alone on survival in
glioblastoma in a randomised phase III study: 5-year analysis of
the EORTC-NCIC trial. Lancet Oncol. 10:459–466. 2009.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Liu P, Li P, Lei T, Qu L, Huang H and Mu
Q: Acute lymphoblastic leukemia following temozolomide treatment in
a patient with glioblastoma: A case report and review of the
literature. Oncol Lett. 15:8663–8668. 2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Strobel H, Baisch T, Fitzel R, Schilberg
K, Siegelin MD, Karpel-Massler G, Debatin KM and Westhoff MA:
Temozolomide and other alkylating agents in glioblastoma therapy.
Biomedicines. 7(69)2019.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Oike T, Suzuki Y, Sugawara K, Shirai K,
Noda SE, Tamaki T, Nagaishi M, Yokoo H, Nakazato Y and Nakano T:
Radiotherapy plus concomitant adjuvant temozolomide for
glioblastoma: Japanese mono-institutional results. PLoS One.
8(e78943)2013.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Lee SY: Temozolomide resistance in
glioblastoma multiforme. Genes Dis. 3:198–210. 2016.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Hoter A and El-Sabban ME: The HSP90
family: Structure, regulation, function, and implications in health
and disease. Int J Mol Sci. 19(2560)2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Altieri DC: Hsp90 regulation of
mitochondrial protein folding: From organelle integrity to cellular
homeostasis. Cell Mol Life Sci. 70:2463–2472. 2013.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Altieri DC, Stein GS and Lian JB: TRAP-1,
the mitochondrial Hsp90. Biochim Biophys Acta. 1823:767–773.
2012.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Dutta R and Inouye M: GHKL, an emergent
ATPase/kinase superfamily. Trends Biochem Sci. 25:24–28.
2000.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Meyer P, Prodromou C, Hu B, Vaughan C, Roe
SM, Panaretou B, Piper PW and Pearl LH: Structural and functional
analysis of the middle segment of hsp90: Implications for ATP
hydrolysis and client protein and cochaperone interactions. Mol
Cell. 11:647–658. 2003.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Soti C, Vermes Á, Haystead TA and Csermely
P: Comparative analysis of the ATP-binding sites of Hsp90 by
nucleotide affinity cleavage: A distinct nucleotide specificity of
the C-terminal ATP-binding site. Eur J Biochem. 270:2421–2428.
2003.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Siegelin MD, Dohi T, Raskett CM, Orlowski
GM, Powers CM, Gilbert CA, Ross AH, Plescia J and Altieri DC:
Exploiting the mitochondrial unfolded protein response for cancer
therapy in mice and human cells. J Clin Invest. 121:1349–1360.
2011.PubMed/NCBI View
Article : Google Scholar
|
|
18
|
Kang BH and Altieri DC: Compartmentalized
cancer drug discovery targeting mitochondrial Hsp90 chaperones.
Oncogene. 28:3681–3688. 2009.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Masgras I, Sanchez-Martin C and Colombo G:
The chaperone TRAP1 as a modulator of the mitochondrial adaptations
in cancer cells. Front Oncol. 7(58)2017.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Zhang D, Dai D, Zhou M, Li Z, Wang C, Lu
Y, Li Y and Wang J: Inhibition of Cyclin D1 expression in human
glioblastoma cells is associated with increased temozolomide
chemosensitivity. Cell Physiol Biochem. 51:2496–2508.
2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Chou TC: Drug combination studies and
their synergy quantification using the Chou-Talalay method. Cancer
Res. 70:440–446. 2010.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Im CN: Past, present, and emerging roles
of mitochondrial heat shock protein TRAP1 in the metabolism and
regulation of cancer stem cells. Cell Stress Chaperones.
21:553–562. 2016.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Marchenko ND: Mitochondrial death
functions of p53. Mol Cell Oncol. 1(e955995)2014.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Chipuk JE, Kuwana T, Bouchier-Hayes L,
Droin NM, Newmeyer DD, Schuler M and Green DR: Direct activation of
Bax by p53 mediates mitochondrial membrane permeabilization and
apoptosis. Science. 303:1010–1014. 2004.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Kulek AR, Anzell A, Wider JM, Sanderson TH
and Przyklenk K: Mitochondrial quality control: Role in cardiac
models of lethal ischemia-reperfusion injury. Cells.
9(214)2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Baqri RM, Pietron AV, Gokhale RH, Turner
BA, Kaguni LS, Shingleton AW, Kunes S and Miller KE: Mitochondrial
chaperone TRAP1 activates the mitochondrial UPR and extends
healthspan in Drosophila. Mech Ageing Dev. 141-142:35–45.
2014.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Takemoto K, Miyata S, Takamura H, Katayama
T and Tohyama M: Mitochondrial TRAP1 regulates the unfolded protein
response in the endoplasmic reticulum. Neurochem Int. 58:880–887.
2011.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Zhang L, Wang X, Cueto R, Effi C, Zhang Y,
Tan H, Qin X, Ji Y, Yang X and Wang H: Biochemical basis and
metabolic interplay of redox regulation. Redox Biol.
26(101284)2019.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Perillo B, Di Donato M, Pezone A, Di Zazzo
E, Giovannelli P, Galasso G, Castoria G and Migliaccio A: ROS in
cancer therapy: The bright side of the moon. Exp Mol Med.
52:192–203. 2020.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Marenco-Hillembrand L, Wijesekera O,
Suarez-Meade P, Mampre D, Jackson C, Peterson J, Trifiletti D,
Hammack J, Ortiz K, Lesser E, et al: Trends in glioblastoma:
Outcomes over time and type of intervention: A systematic evidence
based analysis. J Neurooncol. 147:297–307. 2020.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Weller M, Le Rhun E, Preusser M, Tonn JC
and Roth P: How we treat glioblastoma. ESMO Open. 4 (Suppl
2)(e000520)2019.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Pietrafesa M, Maddalena F, Possidente L,
Condelli V, Zoppoli P, Li Bergolis V, Rodriquenz MG, Aieta M, Vita
G, Esposito F and Landriscina M: Gene copy number and
Post-transductional mechanisms regulate TRAP1 expression in human
colorectal carcinomas. Int J Mol Sci. 21(145)2019.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Lettini G, Maddalena F, Sisinni L,
Condelli V, Matassa DS, Costi MP, Simoni D, Esposito F and
Landriscina M: TRAP1: A viable therapeutic target for future cancer
treatments? Expert Opin Ther Targets. 21:805–815. 2017.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Hua G and Zhang Q: Heat shock protein 75
(TRAP1) antagonizes reactive oxygen species generation and protects
cells from granzyme M-mediated apoptosis. J Biol Chem.
282:20553–20560. 2007.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Zhang P, Lu Y, Yu D, Zhang D and Hu W:
TRAP1 provides protection against myocardial ischemia-reperfusion
injury by ameliorating mitochondrial dysfunction. Cell Physiol
Biochem. 36:2072–2082. 2015.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Kazlauskaite A, Kondapalli C, Gourlay R,
Campbell DG, Ritorto MS, Hofmann K, Alessi DR, Knebel A, Trost M
and Muqit MM: Parkin is activated by PINK1-dependent
phosphorylation of ubiquitin at Ser65. Biochem J. 460:127–139.
2014.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Goiran T, Duplan E, Rouland L, El Manaa W,
Lauritzen I, Dunys J, You H, Checler F and Alves da Costa C:
Nuclear p53-mediated repression of autophagy involves PINK1
transcriptional down-regulation. Cell Death Differ. 25:873–884.
2018.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Lin Q, Li S, Jiang N, Shao X, Zhang M, Jin
H, Zhang Z, Shen J, Zhou Y, Zhou W, et al: PINK1-parkin pathway of
mitophagy protects against contrast-induced acute kidney injury via
decreasing mitochondrial ROS and NLRP3 inflammasome activation.
Redox Biol. 26(101254)2019.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Singh A, Kukreti R, Saso L and Kukreti S:
Oxidative stress: A key modulator in neurodegenerative diseases.
Molecules. 24(1583)2019.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Ozben T: Oxidative stress and apoptosis:
Impact on cancer therapy. J Pharm Sci. 96:2181–2196.
2007.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Simon HU, Haj-Yehia A and Levi-Schaffer F:
Role of reactive oxygen species (ROS) in apoptosis induction.
Apoptosis. 5:415–418. 2000.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Poetsch AR: The genomics of oxidative DNA
damage, repair, and resulting mutagenesis. Comput Struct Biotechnol
J. 18:207–219. 2020.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Shan F, Shao Z and Jiang S: Erlotinib
induces the human non-small-cell lung cancer cells apoptosis via
activating ROS-dependent JNK pathways. Cancer Med. 5:3166–3175.
2016.PubMed/NCBI View Article : Google Scholar
|
